Atlas Trials

Effects of Rosiglitazone and Metformin on Metabolism in Type 2 Diabetes

Clinical trial NCT02526615 · COMPLETED

Trial details

NCT number
NCT02526615
Sponsor
Turku University Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Insulin SensitivityType 2 Diabetes
Start date
2000-10-01
Primary completion
2001-12-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.